Peking and Rotterdam on Mission to Reduce Coronary Artery Disease
NCT01653119
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
1000
Enrollment
OTHER
Sponsor class
Conditions
Acute Coronary Syndrome
Diabetes Mellitus
Interventions
DRUG:
Rosuvastatin
Sponsor
Peking University Third Hospital